Genprex Shares Rise After Collaboration With Roche Diagnostics
Medical research ©rawpixel Genprex Inc. (NASDAQ:GNPX) shares gained 3% on Monday after the clinical-stage biotechnology company announced a…
Novartis targets undruggable cancers with $1.9bn Antares Therapeutics deal
Just a year after spinning out from Scorpion Therapeutics, Antares Therapeutics has secured a big pharma partner to…
Instem Taps ex-Novartis Head of Emerging Technologies to Put Science Behind Practical AI and NAMs
BOSTON, April 15, 2026–(BUSINESS WIRE)–Instem, a leading provider of SaaS solutions for preclinical R&D, today announced the appointment…